LETTER TO THE EDITOR
HIDDEN RISKS OF XYLITOL AND ERYTHRITOL:
A CALL FOR FURTHER RESEARCH
1
4th Military Clinical Hospital, Wrocław, Poland
These authors had equal contribution to this work
Submission date: 2024-06-23
Acceptance date: 2024-06-26
Publication date: 2024-07-04
KEYWORDS
TOPICS
REFERENCES (4)
1.
Reimisz P. Use of low-calorie sweeteners in treating obesity. Health Prob Civil. 2023; 17(2): 145-160. https://doi.org/10.5114/hpc.20....
2.
Witkowski M, Nemet I, Li XS, Wilcox J, Ferrell M, Alamri H, et al. Xylitol is prothrombotic and associated with cardiovascular risk. European Heart Journal. Forthcoming 2024. https://doi.org/10.1093/eurhea....
3.
Witkowski M, Nemet I, Alamri H, Wilcox J, Gupta N, Nimer N, et al. The artificial sweetener erythritol and cardiovascular event risk. Nature Medicine. 2023; 29(3): 710-718. https://doi.org/10.1038/s41591....
4.
Khafagy R, Paterson AD, Dash S. Erythritol as a potential causal contributor to cardiometabolic disease: a mendelian randomization study. Diabetes. 2024; 73(2): 325-331. https://doi.org/10.2337/db23-0....
| eISSN: | 2354-0265 |
| ISSN: | 2353-6942 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
